Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans.
Nature. 2023 May;617(7961):592-598. doi: 10.1038/s41586-023-06025-4. Epub 2023 Apr 3.
Nature. 2023.
PMID: 37011668
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial.
Chalkias S, Eder F, Essink B, Khetan S, Nestorova B, Feng J, Chen X, Chang Y, Zhou H, Montefiori D, Edwards DK, Girard B, Pajon R, Dutko FJ, Leav B, Walsh SR, Baden LR, Miller JM, Das R.
Chalkias S, et al. Among authors: nestorova b.
Nat Med. 2022 Nov;28(11):2388-2397. doi: 10.1038/s41591-022-02031-7. Epub 2022 Oct 6.
Nat Med. 2022.
PMID: 36202997
Free PMC article.
Clinical Trial.
Item in Clipboard
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans.
Alsoussi WB, Malladi SK, Zhou JQ, Liu Z, Ying B, Kim W, Schmitz AJ, Lei T, Horvath SC, Sturtz AJ, McIntire KM, Evavold B, Han F, Scheaffer SM, Fox IF, Parra-Rodriguez L, Nachbagauer R, Nestorova B, Chalkias S, Farnsworth CW, Klebert MK, Pusic I, Strnad BS, Middleton WD, Teefey SA, Whelan SPJ, Diamond MS, Paris R, O'Halloran JA, Presti RM, Turner JS, Ellebedy AH.
Alsoussi WB, et al. Among authors: nestorova b.
bioRxiv [Preprint]. 2022 Sep 22:2022.09.22.509040. doi: 10.1101/2022.09.22.509040.
bioRxiv. 2022.
PMID: 36172127
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Safety and Immunogenicity of a 100 μg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2).
Chalkias S, Schwartz H, Nestorova B, Feng J, Chang Y, Zhou H, Dutko FJ, Edwards DK, Montefiori D, Pajon R, Leav B, Miller JM, Das R.
Chalkias S, et al. Among authors: nestorova b.
medRxiv [Preprint]. 2022 Mar 7:2022.03.04.22271830. doi: 10.1101/2022.03.04.22271830.
medRxiv. 2022.
PMID: 35291289
Free PMC article.
Preprint.
Item in Clipboard
Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial.
Chu L, Vrbicky K, Montefiori D, Huang W, Nestorova B, Chang Y, Carfi A, Edwards DK, Oestreicher J, Legault H, Dutko FJ, Girard B, Pajon R, Miller JM, Das R, Leav B, McPhee R.
Chu L, et al. Among authors: nestorova b.
Nat Med. 2022 May;28(5):1042-1049. doi: 10.1038/s41591-022-01739-w. Epub 2022 Mar 3.
Nat Med. 2022.
PMID: 35241844
Free PMC article.
Clinical Trial.
Item in Clipboard
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis.
Choi A, Koch M, Wu K, Chu L, Ma L, Hill A, Nunna N, Huang W, Oestreicher J, Colpitts T, Bennett H, Legault H, Paila Y, Nestorova B, Ding B, Montefiori D, Pajon R, Miller JM, Leav B, Carfi A, McPhee R, Edwards DK.
Choi A, et al. Among authors: nestorova b.
Nat Med. 2021 Nov;27(11):2025-2031. doi: 10.1038/s41591-021-01527-y. Epub 2021 Sep 15.
Nat Med. 2021.
PMID: 34526698
Free PMC article.
Clinical Trial.
Item in Clipboard
A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine.
Chu L, McPhee R, Huang W, Bennett H, Pajon R, Nestorova B, Leav B; mRNA-1273 Study Group.
Chu L, et al. Among authors: nestorova b.
Vaccine. 2021 May 12;39(20):2791-2799. doi: 10.1016/j.vaccine.2021.02.007. Epub 2021 Feb 9.
Vaccine. 2021.
PMID: 33707061
Free PMC article.
Clinical Trial.
Item in Clipboard
Synthesis and antibacterial activity of 7 beta-[3-(un)substituted-2-aminopropionamido]-3-vinylcephalosporin s and related compounds.
Nestorova B, Pajpanova T, Simova S, Tabakova S, Golovinsky E, Haimova M.
Nestorova B, et al.
Arch Pharm (Weinheim). 1995 Jun;328(6):551-5. doi: 10.1002/ardp.19953280615.
Arch Pharm (Weinheim). 1995.
PMID: 7677572
Item in Clipboard
Cite
Cite